Literature DB >> 33820985

Author Correction: Targeted pharmacological therapy restores β-cell function for diabetes remission.

Stephan Sachs1,2,3,4, Aimée Bastidas-Ponce1,4,5,6, Sophie Tritschler1,4,7,8, Mostafa Bakhti1,4,5, Anika Böttcher1,4,5, Miguel A Sánchez-Garrido2, Marta Tarquis-Medina1,4,5,6, Maximilian Kleinert2,9, Katrin Fischer2,3, Sigrid Jall2,3, Alexandra Harger2, Erik Bader1, Sara Roscioni1, Siegfried Ussar4,6,10, Annette Feuchtinger11, Burcak Yesildag12, Aparna Neelakandhan12, Christine B Jensen13, Marion Cornu13, Bin Yang14, Brian Finan14, Richard D DiMarchi14,15, Matthias H Tschöp2,3,4, Fabian J Theis16,17,18, Susanna M Hofmann19,20,21, Timo D Müller22,23,24, Heiko Lickert25,26,27,28.   

Abstract

Entities:  

Year:  2020        PMID: 33820985     DOI: 10.1038/s42255-020-0201-1

Source DB:  PubMed          Journal:  Nat Metab        ISSN: 2522-5812


× No keyword cloud information.
  1 in total

Review 1.  Debates in Pancreatic Beta Cell Biology: Proliferation Versus Progenitor Differentiation and Transdifferentiation in Restoring β Cell Mass.

Authors:  Erick Spears; Ioannis Serafimidis; Alvin C Powers; Anthony Gavalas
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-06       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.